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Section I: Abstract
Vaccine hesitancy during the COVID-19 pandemic has been an issue in several minority
communities since the initial discussions of the emergency use of the experimental Moderna and
Pfizer vaccines (Increased risk, 2020). The aim of this project is to standardize the patient
outreach process to increase COVID-19 vaccine uptake, particularly in the Latinx community.
Patients at a community clinic in Oakland, California have made apparent their distrust of the
healthcare system and their disbelief in the positive outcomes of the COVID-19 vaccine. Most of
these patients are Latinx-identifying and are considered more at risk for development of COVID19 in the United States (Increased risk, 2020). The clinical group determined their refusal stems
from lack of education and an overall non-standardized outreach process. The objective of this
quality improvement project is to standardize and increase efficiency of the outreach process,
using a multimodal approach to better serve the needs of the Latinx population it serves and
increase vaccine uptake in this population. Using CNL skills, including outcomes management
and education, the quality improvement project focused on the success of the intervention by
comparing the number of vaccine appointments made pre- and post-implementation of the
intervention. The team was unable to implement the intervention at the community clinic.
However, the team used a comprehensive literature review and analysis to predict the possible
and desired outcomes. In a hypothetical situation, the intervention of a standardized outreach
process should increase vaccine appointments and improve overall documentation and phone call
processes. While the source of the problem is rooted in historical implications, the
recommendations may be considered a short-term solution to larger and overarching issues.
Keywords: vaccine hesitancy; COVID-19 vaccine; Latinx; vaccine education; outreach
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Section II: Introduction
American institutions have been impacted by racism made evident in the contemporary
issues of socio-political unrest we have witnessed within the last four years after the 2016
presidential election (Frakt, 2020). The healthcare institution is not immune to this
discrimination as the health outcomes of People of Color (PoC), specifically Black and Latinx
individuals, have been negatively affected (Frakt, 2020). While this project focuses on Latinx
individuals, it is important to note the similarities in both populations’ outcomes with relation to
racism and bias within the United States. Incidents like the Tuskegee Syphilis Study and the
story of Henrietta Lacks have caused fear and anger within communities with PoC. Ultimately,
historical and institutional racism has led to a mistrust in the healthcare profession (Frakt, 2020).
As Hardenman et al. (2016) puts it, “Finally, to provide clinical care and conduct research that
contributes to equity, we believe it is crucial to ‘center at the margins’ – that is, to shift our
viewpoint from a majority of group’s perspective to that of the marginalized group or groups.”
Healthcare providers have attempted to bring this issue to light to improve health outcomes and
equity for all communities, especially those most impacted by discrimination within the
healthcare system.
Currently, the global community is responding to the novel coronavirus discovered in
2019 (COVID-19), which resulted in worldwide infections and loss of life (Increased risk,
2020). The COVID-19 pandemic, which has highlighted gaps and inequities within American
institutions, but especially within the healthcare system. The Centers for Disease Control and
Prevention (CDC) has created a strategy to respond to health inequity in the COVID-19 response
within the United States (CDC, 2020). One of the recommendations outlined by this CDC
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strategy is to study the needs of vulnerable and marginalized populations through collection of
data related to cultural and belief systems. The information should then be used to create
programs specifically targeting improved outcomes for said populations (CDC, 2020). These
strategies should be culturally appropriate and person-centered to be the most successful in
achieving the desired outcome.
In January of 2021, the U.S. Food and Drug Administration (USFDA) announced the
emergency use of an experimental COVID-19 vaccine, which is produced by three companies:
Pfizer, Moderna, and Johnson & Johnson. Although, the release of these vaccines to the general
public has ignited hope for citizens to return to the world before the pandemic, it has created
issues in the way healthcare institutions conduct outreach to distribute the vaccine to the
communities they serve. Per the CDC’s recommendations, it is important to strategize and plan
for vaccine hesitance or resistance, especially within the Black and Latinx population (CDC,
2020). The CDC’s recommendations have paved the way for this group to study a community
clinic’s effectiveness in the process of calling and making COVID-19 vaccine appointments
among eligible community members in Oakland, California. The process of a patient choosing to
receive the COVID-19 is defined as vaccine uptake (Baumegaertner et al., 2020).
Problem Description
At a community clinic in Oakland, California, more than half of the clients served are
Latinx-identifying (About, 2020). In this context, Latinx individuals are those individuals who
are from or have ancestry in Mexico, Central and South America (Britannica, n.d.). The same
population is also primarily Spanish-speaking and living below 200% of the poverty line, per
demographic information provided by the clinic (“Connecting Communities,” 2017). The CDC

STANDARDIZED OUTREACH

7

considers the Latinx community a vulnerable population in that they are a community of people
who are more likely to experience negative health outcomes compared to White non-Latinx
individuals. Boakye et al. (2017) highlights educational gaps in knowledge surrounding efficacy
of general vaccines in the Latinx community. Additionally, Latinx individuals are less likely to
obtain optional vaccines like the HPV vaccine (Boakye et al., 2017). Specifically, individuals
who refuse the vaccine are considered vaccine resistant. Those who are not confident in the
efficacy of vaccines or have verbalized barriers to receiving a vaccine are considered vaccine
hesitant. However, it is important to note the negative connotation associated with vaccine
hesitancy as this often places blame and shames individuals who are considered vaccine hesitant
(Calderon-Mora et al., 2020). The terms vaccine hesitancy and vaccine resistance are important
distinctions to make as the group attempts to analyze responses from patients and improve the
COVID-19 vaccine appointment process.
Currently, staff at the Oakland community clinic use an electronic medical record (EMR)
to identify individuals who are eligible for the COVID-19 vaccine. After identifying eligible
community members, staff use the demographic information in the EMR to contact the patients
via telephone. During the call, staff members inform the patient they are eligible to receive the
vaccine at the vaccination clinic, which is managed by the community clinic and offer an
appointment. Should the patient ask questions about the vaccine, the staff are provided with basic
information about the vaccine to share with them. If the patient agrees to receiving the vaccine,
the staff member then schedules an appointment over the phone and provides registration
instructions and the vaccine clinic location to the patient.
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Through interviews with the Clinical Manager, Clinical Educator, and Patient Outreach
Coordinator, the team received anecdotal evidence suggesting nearly half of the individuals who
were contacted to make an appointment to receive the COVID-19 vaccine were reluctant and
displayed vaccine resistance related to lack of education. These individuals verbalized their
distrust of the vaccine’s efficacy in preventing transmission of COVID-19. However, through
anecdotal evidence the team also learned these individuals lacked knowledge about how the
vaccine prevented transmission. Furthermore, staff reported frustration from patients as some
individuals were accidentally contacted more than once. This was due to a non-standardized
phone call process where staff members did not document phone calls.
Since phone calls were not documented and the reasons for vaccine resistance, hesitance,
and acceptance were also not documented, the staff were unable to review data and identify
common values or potential areas requiring specific education. This issue was further impacted
by the lack of staff who were dedicated specifically to making phone calls and contacting
eligible patients for a COVID-19 vaccine appointment. Often, staff were taken from their regular
duties and assigned to make phone calls. The shortage of staff reportedly led to burnout and
varying staff members involved in the phone call process resulted in inconsistency in the quality
of phone calls. Staff members were not educated or provided training sessions to discuss
educational material to be shared with patients. Consequently, the shortage of staff,
inconsistency of staff making phone calls, and lack of documentation resulted in multiple calls
made to one patient. This often resulted in patients who became upset and frustrated with staff.
As more staff members reported patients’ frustrated responses to phone calls, the clinic
made the decision to cease conducting phone calls altogether. Overall, in the clinic’s attempt to
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contact patients above the age of 65 during the first phase of vaccine roll-out were able to
schedule approximately 47% of the patients they contacted. According to anecdotal evidence, the
53% who refused to make a vaccine appointment displayed mistrust and fear. This made clear
the need for culturally appropriate and specific interventions to increase vaccine uptake among
the Latinx population in this community served by the clinic in Oakland, California. Without an
evidence-based and standardized phone call process, the issue of vaccine hesitancy and refusal
could result in a continued disproportionate impact of COVID-19 of the Latinx patients in this
community. As a result, the CDC is encouraging targeted efforts to provide vaccinations to
vulnerable communities, such as the Latinx community (Disparities, 2020). There are significant
financial implications should the institution follow recommendations outlined by the clinical
leadership group. Additionally, the process of standardizing phone calls can prove to be a model
for teaching and learning from patients which can have significant historical implications in the
future design of culturally appropriate care models.
Available Knowledge
The PICOT question used for the literature search and synthesis of evidence for the
phone call process standardization project asks: In patients who are receiving a phone call to
schedule an appointment for the COVID-19 vaccine (P), will educating the staff on a multimodal
standardized outreach intervention (I) compared to the current outreach process (C) improve
COVID-19 uptake (O) in 4 weeks (T)? A comprehensive literature review was completed with
the assistance of the institution research expert. From the literature review, the data were
synthesized using the database, PubMed. The database was searched using the main topics and
themes from the PICOT question and included the following keywords in the search: vaccine
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hesitancy; COVID-19 vaccine; Latino, Latina, Hispanic, Latinx; vaccine education; outreach;
vaccine literacy, and vaccine refusal. Limitations such as peer-reviewed articles and publication
dates no earlier than 2010 were placed. Over 50 articles were chosen based on relevance to the
PICOT question and the population group included in the studies. The studies used in the
planning and evaluation of the intervention were chosen based on their applicability to the
PICOT with regard to COVID-19 and perceptions of the vaccine.
One recent study by Ruiz and Bell (2021) shared results of a survey poll conducted prior
to the release of the COVID-19 vaccine when the news of a potential authorization date for the
COVID-19 vaccine was released. The study analyzed elements such as vaccine knowledge,
COVID-19 risk factors, and knowledge of the novel coronavirus. The results concluded that a
significant amount of the over 800 participants in the study had little to no intent of receiving the
vaccine (Ruiz & Bell, 2021). Latinx and Black-identifying participants were among the
individuals who had the least intent of receiving the vaccine. The researchers found that overall
vaccine hesitancy was determined by a combination of factors including demographic
characteristics, vaccine knowledge, perceived vulnerability, risk factors of COVID-19, and
politics (Ruiz & Bell, 2021). This is concerning because these are communities already
disproportionately affected by COVID-19 and to know they are the least likely to choose to
receive the vaccine could result in an overall negative impact of COVID-19 on these
communities. However, this informs the group’s project and confirms concerns for public
healthcare workers, resulting in a need to address these concerns now.
Similarly, a study by Romer and Jamieson (2020), identified three main conspiracy
theories wherein participants answered an online survey poll about which conspiracy theory they
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believed to be true. The three conspiracy beliefs the researchers presented to participants were:
(1) The pharmaceutical industry created the coronavirus to increase sales of its drugs and
vaccines, (2) The coronavirus was created by the Chinese government as a biological weapon,
and (3) Some in the U.S. Centers for Disease Control and Prevention (CDC), are exaggerating
the danger posed by the coronavirus to damage the Trump presidency (Romer & Jamieson,
2020). Again, Latinx and non-White respondents were more likely to believe in one of the
conspiracy theories. These two studies by Ruiz and Bell (2021) and Romer and Jamieson (2020),
highlight the lack of knowledge surrounding the vaccine and why the staff are seeing a
downward trend in vaccine uptake from the community members served by the Oakland
community clinic. Understanding these conspiracy theories can help inform the group’s approach
to having an open discussion with patients and community members over the phone during the
outreach process.
Furthermore, a systematic literature review of articles and empirical research studies
focused on barriers to vaccine access in Latin America. The review identified several barriers
which impacted one’s access to vaccines. These barriers included unfavorable socioeconomic
factors, lower levels of education, lack of awareness of disease and vaccines, and religious and
cultural beliefs (Guzman-Holst et al., 2020). Additionally, the same systematic review identified
other studies in which individuals with higher levels of educational attainment were more likely
to receive regular vaccinations and follow recommended vaccine schedules (Guzman-Holst et
al., 2020). Overall, education is a proven significant factor in the decision-making process of a
choice that has an impact on one’s health and confirms the need for the group’s project. See
Appendix A for the evaluation table of evidence-based research.
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A qualitative study by Fauza Malik et al. (2020) studied Latin American pregnant
womens’ attitudes towards provider recommendations on preventative treatments were impacted
by the trust reflected in their relationship with their healthcare provider and the healthcare
institution. While the population focus is specific to pregnant women in Latin America, the
results of the study are still relevant to this group’s project. Fauza Malik et al. (2020) found
educational attainment, understanding of vaccine efficacy during pregnancy, religious beliefs,
and awareness of diseases impacted a pregnant woman’s decision to accept recommendations by
the healthcare provider. This study provides context and emphasizes the need for trust between
patient and the person making a recommendation for improved quality of health. Therefore, the
group’s proposed intervention considers the need to create an open, supportive, and trusting
relationship with patients during the outreach process.
An empirical research study conducted by Baumegaertner et al. (2020) researched
vaccine propensity, or a change in willingness to vaccinate with a change in perceived risk of
infection. Overall, the study found there was a higher chance for vaccine propensity, in which
individuals changed their mind in vaccine uptake and decided to take the vaccine. This decision
was made after the patient’s perceived risk of mortality resulting from infection was higher
without the vaccine (Baumegaertner et al., 2020). While it is important to create a space for open
discussion regarding fears and concerns related to receiving the vaccine, it is equally important
for the group to recognize the need to have an honest conversation with community members
regarding the risks of COVID-19 infection without the vaccine.
The body of evidence in the literature review phase of this project revealed educational
attainment and individual sociopolitical beliefs play a significant role in the decision-making
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process of receiving the COVID-19 vaccine. Therefore, it is important that healthcare
institutions, providers, and healthcare workers who work directly with these vulnerable
individuals, understand the need for culturally and person-centered intervention planning
(Boakye et al., 2017). Motivational interviewing techniques have proven to be significantly
impactful in other studies where a change in motivation is needed for an individual to make a
decision about a treatment that has a consequential impact on a positive health outcome (Fauzia
et al., 2020). Combining education with motivational interviewing has the potential to make an
impact in the group’s focus population of the Latinx community. See Appendix A for the
evaluation of literature.
Rationale
Kurt Lewin’s change model will form the conceptual framework for the planning and
implementation of intervention created from this project. Lewin’s change model will be
combined with the group’s leadership and knowledge and used to influence the need for change
in the microsystem at the Oakland community clinic. The change model focuses on generating a
need for the change within the microsystem to further produce buy-in and participation from the
staff. Lewin’s change model will provide a foundation from which the team can engage with the
staff to implement the change and increase effectiveness.
The three major phases of Lewin’s change model are (1) unfreezing, (2) changing, and
(3) refreezing (Hussain et al., 2016). The first phase, unfreezing, is the phase in which leadership
who are attempting to create change, considered innovators, must determine what in the
microsystem or process in the microsystem must change. Additionally, the innovators must
ensure strong leadership is established to support the change. In the unfreezing phase, the
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innovators must also create a need for change while managing and understanding the doubts and
concerns voiced by those affected by the change (Hussain et al., 2016).
In the second phase of Lewin’s change model, changing, the innovators have planned a
change and are prepared to implement it in the microsystem or a process. Therefore, this phase
necessitates increased communication to identify gaps in implementation of the change.
Additionally, the innovators must be prepared to dispel rumors while empowering those
implementing the change with action. This phase also necessitates teamwork and collaboration,
therefore innovators mut also involve staff in the process (Hussain et al., 2016). This phase
consists of several moving parts wherein the innovators are responsible for carrying out the
change while observing gaps or need for adjustment.
In the third and final phase of Lewin’s change model, refreezing consists of establishing
the permanence of the change (Hussain et al., 2016). In establishing permanence, the innovators
will ultimately change the culture of a microsystem. The innovators will develop a sustainability
plan to continue the change and maintain the progress and outcomes resulting from the change.
This can be accomplished by creating a support team and training (Hussain et al., 2016). In the
group’s change project, the group requires the participation and cooperation of the staff at the
community clinic in Oakland to be successful in not only implementing the change but in its
adoption into the culture of the clinic. Once the project is adopted into the culture of the clinic,
then sustainability is easier to achieve.
Specific Project Aim Statement
The aim for the quality improvement project is to standardize the outreach process at this
community clinic in Oakland, California in order to increase the amount of COVID-19 vaccine
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appointments from 47% to at least 70% by May 2021. The process began the first week of
February 2020 with observation and assessment of the community clinic in Oakland, California.
The process ends with evaluation of the standardization in the phone call process. The group
expects to see an overall increase in the amount of vaccine appointments made through patient
phone calls. It is important to work on this now because Latinx individuals are disproportionately
affected by the pandemic and reducing the transmission of disease is necessary to preserve
human life.
The group developed a survey to be completed during phone calls. Documentation
standards were created to document necessary information from phone calls from which the staff
can identify trends and patterns that can inform further changes in educational materials. The
goal is to educate staff on motivational interviewing, the survey to be conducted in the phone call
process, and proper documentation of phone calls. Upon completion and implementation of the
intervention, the group planned to review patient surveys regarding the phone call experience
and review documentation from staff to measure compliance to change.
Section III: Methods
Context
The community clinic in which the group is conducting the quality improvement project
is located in a rural neighborhood of Oakland, California which serves primarily working-class,
Spanish-speaking, Latinx community members (“Connecting Communities,” 2017). The clinic
was established and began operation in the 1970s with a goal to serve low-income communities
in the East Bay region of California (“About,” 2020). The clinic has the space and skilled staff to
provide care in several medical areas, including pediatric care, prenatal care, women’s wellness,
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behavioral health, urgent care, dentistry, and family medicine. This clinic focuses on providing
equitable and comprehensive preventative care services. Therefore, with the onset of the
COVID-19 pandemic and general vaccine hesitancy among the Latinx community, it has become
the center for the intersection of two issues: preventing transmission of COVID-19 and historical
mistrust in the healthcare community.
Reducing transmission of the novel coronavirus, COVID-19, relies on the participation
and collaboration of community efforts in mask-wearing, hand hygiene, social distancing, and
isolation of individuals who are sick or who suspect illness with the novel coronavirus (“Protect
Yourself,” 2021). Now, the United States Food and Drug Administration has authorized the
emergency use of two COVID-19 vaccines, Pfizer and Moderna vaccines. Due to the rapid
creation of the vaccines, this has caused many individuals to speculate the vaccine’s safety and
efficacy. Speculation eventually results in hesitancy and outright refusal of the vaccine, which is
evident in the nearly half of individuals who refuse the vaccine when they are contacted for an
appointment by staff members at the Oakland community clinic.
To identify issues or processes requiring change, the clinical leadership group understood
the need for an awareness and understanding of the current processes and culture within the
microsystem. Understanding the culture and the components contributing to a microsystem’s
progress is essential to identifying gaps in a process. Furthermore, understanding the components
of a microsystem results in the understanding of staff roles, the impact of choices made by the
leadership team, and insight into the dynamic of these groups working together.
Microsystem Assessment
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The Family Medicine unit, a microsystem within a community clinic in Oakland,
California, was assessed using the 5 P’s Microsystem Assessment. In the 5 P’s Microsystem
Assessment, the group identified the purpose of the microsystem assessment, the patients this
unit serves, the professionals working in this unit, the process being studied, and the pattens
identified in the process. The purpose of the Family Medicine unit is to provide preventative
services to children and adults. These services include general wellness assessments, medication
reconciliation, and problem-focused assessments. This unit also provides scheduled vaccinations,
therefore as part of the national roll-out of the COVID-19 vaccines, the unit created a vaccine
clinic to provide vaccinations to patients and community members.
The patients this clinic serves are primarily Latinx-identifying and Spanish-speaking
(“Connecting Communities,” 2017). Within the microsystem, several professionals were
identified including registered nurses providing care, medical doctors and physician overseeing
treatments and prescriptions, the Clinical Manager, the Clinical Educator, and the Patient
Outreach Coordinator. The Clinical Manager oversees the general management of the
community clinic, including the COVID-19 vaccine clinic. The Clinical Educator manages and
coordinators outreach and education efforts to patients served by the community clinic. The
Patient Outreach Coordinator oversees the phone call process to patients and the staffing of the
phone services for the community clinic.
The group conducted interviews with the Patient Outreach Coordinator to discuss the
process of calling patients by telephone and scheduling the COVID-19 vaccine appointment. The
process begins with a staff member who is a registered nurse or medical assistant, uses the EMR
to identify patients who are eligible for the COVID-19 vaccine. The staff member then calls the
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patient using the phone number associated with that medical record and asks the patient if they
would like to make an appointment to receive the COVID-19 vaccine. The vaccine provided by
the community clinic is the Moderna and Pfizer vaccines, requiring two doses and
consequentially two appointments. If the patient has questions, the staff members provide limited
and non-standardized education and information. The patient has the option to speak to a
provider at another time. The group identified several patterns including no documentation of the
phone call resulting in multiple calls made to one person, misidentification of a patient resulting
in an appointment made for a patient’s son rather than the patient and limited educational
material.
SWOT Analysis
Upon completion of the 5 P’s Microsystem Assessment, the group conducted a SWOT
Analysis of the community clinic, see Appendix B. This analysis resulted in the group’s
identification of strengths, weaknesses, opportunities for change implementation, and threats to
the desired outcome. By focusing on these four elements of a microsystem, the group can
facilitate further awareness of the microsystem and therefore, it prepares the group to collaborate
and plan an intervention. The SWOT analysis provides the group with a common foundation
from which to initiate planning and a visual for focus areas (Harris et al., 2018).
In identifying strengths, the group agreed the community clinic is well-established and
well-known as it has been operating for nearly fifty years. The staff are skilled and
knowledgeable about the community in the city of Oakland. The clinic has educational materials
from which the group can build and create improved educational materials. Furthermore, the
clinic has an established access to county and CDC information. When identifying weaknesses,
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the group identified financial issues as a direct result of the pandemic, leading to decreased or
limited in-person visits and ultimately resulting in loss of revenue. Furthermore, weekly changes
to vaccination and phone call processes by the clinic leadership team results in
miscommunication and non-standardized phone call processes.
The group found several opportunities for change implementation, including support
from other community-based clinics in the county and media coverage of the vaccination site
promoting use. Additionally, the clinic has well-established connections and has initiated
outreach efforts in local churches, grocery stores, and senior centers. Since the clinic has
established a presence in these community amenities, patients and community members are more
likely to receive a vaccine through the clinic. However, these opportunities are threatened by
several factors. Earlier this year, southern and eastern states within the United States experienced
intense and unexpected weather events, which impacted the distribution of vaccines.
Furthermore, if patients do not accept education or if the education is inadequate then they are
less likely to agree to a vaccine appointment. These threats are further magnified by
misinformation released by media.
GANTT Chart
The group developed a GANTT chart to create a visual representation of the timeline for
the assessment, planning, implementation, and evaluation of the quality improvement project.
The GANTT chart was developed using weeks and months to outline the progress and general
markers to display when actions and items should be completed. See Appendix C to view the
weekly progress of the quality improvement project. The GANTT chart created by the group
outlines the Plan-Do-Study-Act (PDSA) cycle that was anticipated to be completed. Note the

STANDARDIZED OUTREACH

20

GANTT chart outlines hypothetical milestones and phases as the group was unable to implement
the planned intervention. As outlined by the GANTT chart, the group intends to implement this
change within four weeks and evaluate the outcomes on Week 7 and every week thereafter.
Intervention
Plan-Do-Study-Act (PDSA)
A PDSA cycle was conducted as a framework to conduct this quality improvement
project. See Appendix D for the phases of Plan-Do-Study-Act outlined in the GANTT chart. The
PDSA provides the group with a step-by-step approach to this large-scale project that has the
potential to impact a community that has been disproportionately affected by COVID-19. The
group was unable to complete the PDSA due to issues beyond scope. However, the group’s
recommendations are informed by literature review and evidence-based practice.
Plan
In identifying the issue for vaccine hesitancy among a majority Latinx-identifying
population, the group first observed the microsystem and assessed current processes. Interviews
with key staff members were also conducted to understand details within the process of phone
calls to community members and patients. Upon assessment completion, the group identified the
focus of the project and developed an aim. The group then conducted a thorough literature
review and literature evaluation, identified changes to test, and created metrics with which to
measure outcomes. Upon completion of the literature review, the group designed a survey for
staff members to complete in addition to the necessary documentation. An example of the survey
is available in Appendix E and is available in both English and Spanish languages. This
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information should then be documented in the EMR. An in-service training was planned to
disseminate this information and discuss the need for this change.
The group also created a patient satisfaction survey, seen in Appendix F, to mail to
patients when they have received a phone call from the clinic to make a vaccine appointment.
The survey focuses on the patient’s overall satisfaction with the phone call, timeliness, and
efficiency of making the appointment. Furthermore, the group used the literature review to
enhance educational materials with more detail and specific to this community’s concerns which
are also reflected in the literature. See Appendix G for enhanced educational material.
Do
The group planned to disseminate information and provide competency training through
in-services which were to be conducted in Weeks 6 and 7. It was planned to initiate the change
on Weeks 6-10 wherein staff members conducting phone calls would use surveys, standardized
educational materials, and complete documentation as instructed in the EMR. Additionally, a cosigner would have been identified to co-sign documentation at the end of each office days when
staff members completed phone calls. When a call is completed to a patient, the staff will send
the patient survey (see Appendix F) to the patient.
Study
The study phase of the PDSA will take place over six weeks, from Weeks 7 to 13. If the
group was able to implement this project, it was planned to evaluate the intervention by
evaluating ongoing performance of the implemented change. The group would have identified
trends in phone calls, discussed with staff members what patterns they have noticed in the
response from their patients upon phone call completion. The group planned to review
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documentation and discuss patterns with the co-signer of the documentation. This review would
help the group identify any areas of the new process requiring adjustment or addition of
knowledge. Additionally, this phase of the PDSA would allow the group to adjust information
and educational materials to be tailored to the needs of the communities. During this time, the
group planned to review the number of phone calls staff members were able to complete prior to
the intervention and compare them to the number of phone calls staff members completed after
the intervention was implemented. This would allow the group to review efficiency as time is
essential in reaching a large amount of community members to schedule vaccine appointments.
Act
The act phase of the PDSA will take place on Week 13 and every week thereafter. It was
planned for the group to implement and adjust needed changes from the study phase of the
PDSA. It was planned to be an ongoing phase of the PDSA cycle where the group and staff
could determine if the change was worth adopting or abandoning.
Financial Analysis
The group conducted a financial analysis to outline the potential costs for the
implementation of the proposed project, see Appendix H. This analysis also takes into
consideration the loss of revenue from the reduced number of in-person visits at the community
clinic. There is cost associated with employing the CNLs to plan, implement and evaluate the
intervention. Additionally, costs exist for the materials to produce educational materials, and
paying the staff for attending training sessions, training conducted by CNLs. In total, the costs
would amount to $1,145.39. However, the group anticipates upon increased vaccine uptake and
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the subsequential herd immunity, the clinic would experience an increase in revenue as more inperson visits take place.
Study of Intervention
As outlined by the ‘Study’ phase of the PDSA displayed in Appendices C and D, the
group planned to study the intervention and measure its effectiveness by comparing the number
of calls made before and after the implementation of the intervention. This would determine
efficiency of the new standardized phone call process after implementing a standardized
education component. The group also planned to calculate the percentage of individuals who
consented to receiving the vaccine and making a vaccine appointment. This percentage would be
compared to the percent of patients who consented to receiving the vaccine and making an
appointment prior to the implementation of the intervention. Additionally, the group planned to
measure adherence to the recommendation of documentation for each patient phone call. These
factors would help determine the effectiveness of the recommended intervention. Furthermore,
the group planned to send patients and community members a patient satisfaction survey (see
Appendix F) to review areas of improvement.
Measures
The group was not able to study the intervention due to unforeseen circumstances. The
results, conclusion, and discussion of this project were predicted based on available knowledge
from the literature review.
Ethical Considerations

STANDARDIZED OUTREACH

24

This project has been approved as a QI project by faculty using QI review guidelines and
does not require IRB approval, see Appendix I for Statement of Determination and NonResearch Determination Form. Ethical considerations made by the leadership team were guided
by the American Nurses Association (ANA) Code of Ethics (2015). Ethical considerations drawn
from the ANA Code of Ethics (2015), included respect for human dignity, autonomy, veracity,
and self-determination. The leadership team is considering respect for human dignity as it relates
to the equitable access to preventive measures for a virus during a global pandemic, highlighting
the desire to increase vaccine uptake. The leadership team also considers autonomy as it relates
to this project as each person has the right to determine what happens to their person and what
measures they want to use and receive. Therefore, the clinical leadership team acknowledges that
the group cannot force any person to receive the vaccine, the group can only educate to allow
individuals to make the most informed decision. This idea ties into veracity as each individual
should be well-informed and their decisions should not be guided by myths and conspiracies.
During the COVID-19 pandemic, many individuals have been guided by fearmongering,
conspiracies, and mistruths (Baumegaertner et al, 2020). Therefore, the group’s project focuses
on providing facts and evidence proven by science. Lastly, the leadership team identified selfdetermination as the last ethical consideration. Every person has a legal right to determine the
care they receive and from what institution they receive it. As such, the group must respect each
person’s decision to receive or not receive the vaccine.
Section IV: Results
The group was unable to implement the change in this quality improvement project at the
community clinic. However, the group has made predictions based on information and results
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from the literature review. One study suggests more time with the provider to have a private
discussion surrounding beliefs, concerns, and conspiracies has the potential to help individuals
choose to become vaccinated (Boakye et al., 2017). Additionally, other studies suggest focus
groups with time dedicated to understanding one’s feelings and concerns about a vaccine and
using motivational interviewing techniques has the potential to help individuals choose to receive
a vaccine (Fauzia Malik, 2020). Overall, the literature suggests the group’s project and
recommendations has a high likelihood for success, resulting in an increased vaccination uptake.
In addition to increasing vaccine uptake, the project can assist the community clinic in
recording responses from patients and using the data to inform future projects and initiatives.
Should the clinic staff identify trends and patterns from individuals sharing concern about a
specific treatment or another vaccine, then the data and educational materials can be used to help
patients make an informed decision. This may also increase a patient’s confidence in a suggested
treatment or vaccine, resulting in their compliance. Accessing organized data in the way the
group is suggesting yields a framework the community clinic can build upon.
Section V: Discussion
Summary
Findings from the literature review suggest this project has a high probability for success.
The literature also suggested this work is necessary as non-White communities require unique
attention to cultural and linguistic characteristics. Furthermore, the literature has made evident
the impact culture and cultural norms have on decision-making processes (Hardenman et al.,
2016). Therefore, focusing on the Latinx population at a community clinic that serves a majority
of Latinx and Spanish-speaking individuals was necessary to reduce transmission of COVID-19
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in the Oakland community. Additionally, the project can improve trust and communication
between staff and community members as the motivational interviewing provides a safe space
for listening and honest discussion (Wermers et al., 2021).
Barriers
There were several barriers to implementing this project, which resulted in the group’s
inability to implement it at the community clinic. The understanding of the CNL role in the
clinical setting is still limited among clinical staff and clinic management. As a result, generating
buy-in from the clinical management team was difficult and ultimately the group was unable to
implement the project. The project is also constrained by time as the group four months to plan,
implement, and evaluate the change. Addressing and eliminating vaccine hesitancy and refusal is
difficult as the issue is rooted in generations of historical and institutional racism and mistrust.
This project requires more time to be effective and address historical implications.
In addition to these barriers, the project had to be completed remotely. Due to COVID-19
and social distancing practices, the group was unable to be on-site at the community clinic to
plan and implement this project. Working from home made interviewing and discussions with
staff members difficult as planning around each person’s schedule can be challenging. This also
resulted in delayed communication and time spent. Shifting priorities were often not
communicated in a timely manner, challenging the group to shift the focus of the project several
times before focusing on the standardization of the phone call process and educational materials.
Financial constraints were another barrier the group attempted to overcome. The
pandemic placed an economic burden on the community clinic, which prompted more
individuals to use telehealth services rather than in-person visits. The drastic decrease in in-
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person visits caused a loss of revenue for the clinic. The loss in revenue puts the clinic in a
strenuous position as management does not have the means to hire more individuals for a call
center dedicated to phone calls for COVID-19 vaccinations or for the vaccine clinic. Existing
staff are strained as they now have additional responsibilities due to the demand for staff to
perform phone calls and to manage the vaccine clinic.
Recommendations
The group recommends investment in resources. While implementing a change,
particularly a change in phone call processes, the associated cost may be more than the clinic is
willing to spend. However, monetary investment is necessary when making a change that can
positively impact health outcomes. Particularly, it is important to recognize the need to provide
resources and increase equitable access to healthcare services for communities who have a
history of being disproportionately affected by illness (Buerger et al., 2021). Furthermore, this is
an opportunity to reduce health care disparities and gaps in outreach. In line with the CNL’s role
to advocate for patients, the group highlights the role of social justice in a healthcare institution,
especially in a community clinic (American Association of Colleges of Nursing, 2007).
Furthermore, literature reviews, review of current trends in the United States, and
creation of goals are recommended for the community clinic to further increase vaccine uptake.
Review of existing data can inform processes and adjustments to fulfill desired outcomes. In
addition to reviewing literature, it is recommended the clinic collaborate with other community
clinics that serve vulnerable populations. Finding other institutions with the same goal to
increase vaccine uptake and review their process to identify successful components of a process
can inform the community clinic’s process to increase vaccine uptake.
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Lastly, the group recommends reviewing the American Association of Colleges of
Nursing’s (2007) outline of the role of the CNL in the clinical setting. As the group is composed
of individuals educated in the role of the CNL, the group is prepared to assess the microsystem,
plan a change, implement it, and evaluate its effectiveness. Furthermore, understanding the role
of the CNL provides a foundation for efficient communication and allows the CNL to practice in
the clinical setting. Allowing the group to act as CNLs in the clinical setting would have allowed
the group to implement the project, therefore providing education and reviewing the role of the
CNL could have changed the group’s approach to the project and allowed for implementation of
the change in the clinic.
Limitations
Several limitations have the potential to interfere with this project. Changing eligibility
tiers for individuals to receive the vaccine will alter the results of the intervention. As more
individuals become eligible to receive the vaccine, more individuals will want the vaccine, thus
increasing vaccine appointments and uptake. It would be difficult to determine of the increase in
vaccine appointments made during the phone calls were a direct result of the educational
component of the phone call or if this had to do with changing eligibility. Lack of historical
evidence has also limited the group’s ability to predict effectiveness and overall success of the
intervention as COVID-19 is the first pandemic since the Spanish flu in the early 1900s.
Therefore, there is little data on how to approach individuals regarding the emergency
authorization of an experimental vaccine.
At the community clinic, the group was only able to interview three staff members: the
Clinical Manager, the Clinical Educator, and the Patient Outreach Coordinator. This limited the
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group’s ability to understand the entire process of making phone calls and could have influenced
the anecdotal evidence received. The clinical group members were unable to talk to staff
members conducting phone calls, resulting in the group’s reliance on the information received
from three staff members.
Clinical Leadership Theme
The clinical leadership roles correlating to this project are outcomes manager, client
advocate, and information manager. The clinical nurse leader’s (CNL) role as an outcomes
manager is to improve the health outcomes of a population and community. Additionally, the
CNL’s role as a client advocate in the context of this project is to use a literature review to
understand the cultural needs and experiences of a population to facilitate education for the
population (AACN, 2007). Furthermore, the CNL’s role as an information manager is to provide
a process and organizational method for which information can be collected in a uniform manner
to be studied later to further improve outcomes for the population. Through this project, the CNL
is enhancing the skill to “develop and use higher-order problem-solving and critical thinking
skills” (AACN, 2007).
Conclusions
While the group was unable to implement this project into practice, the literature review,
planning, and recommendations can be used to provide a framework for a similar project in
another setting. Motivational interviewing techniques and surveys can be used as an example of
how to approach patients when discussing a new preventative practice or treatment. This project
also demonstrates the importance of collaboration and buy-in. Without generating buy-in a group
cannot succeed in implementing a change or improving health outcomes. Furthermore, COVID-
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19 will continue to be a global issue for the foreseeable future as the global community learns to
navigate vaccine accessibility, vaccine hesitancy and vaccine resistance. New variants of the
novel coronavirus also pose threats to the successful prevention of COVID-19. Therefore, this
project can be used as a resource to guide healthcare providers who work with primarily Latinx
and Spanish-speaking individuals.
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Section VII: Appendices
Appendix A. Evaluation Table
PICOT Question:
In patients who are receiving a phone call to schedule an appointment for the COVID-19 vaccine
(P), will educating the staff on a standardized phone call intervention (I) compared to no
intervention (C) improve COVID-19 uptake (O) in 4 weeks (T)?
Study

Design

Baumegaertner Empirical
et al.
research
(2020).

Boakye et al.
(2017)

Fauza Malik et
al.
(2020)

Sample
2,411
individuals in
the United
States
surveyed
online

Outcome/Feasibility

In this study, the research group analyzed vaccine
propensity, which is a change in willingness to vaccinate
with a change in perceived risk of infection. The study
analyzed responses from participants of an online survey
which was completed on Feb. 2018. The results of the
survey showed that respondents had a greater willingness to
be vaccinated with a perceived risk of mortality in the
presence of fewer case counts compared to the risk of
morbidity. Furthermore, the older population and those with
a higher income (>$90,000) were more likely to be
vaccinated as well. Additionally, political ideology and
level of risk influenced willingness to vaccinate.
Empirical 6,862 persons This article discusses an assessment among individuals in
research
above the age the United States regarding knowledge surrounding the
of 18
HPV vaccination. The assessment found that the main
surveyed in
sources of information on HPV were electronic and print.
the Health
The non-Hispanic Black population seemed to be the least
Information
informed about HPV. Both Hispanics and non-Hispanic
National
Black individuals had less knowledge and understanding of
Trends
the HPV vaccine. The researchers found the most influential
Survey
and helpful strategy was the recommendation of the vaccine
by healthcare providers, which increased vaccine uptake.
Qualitative 162 pregnant
Variability in maternal immunization rates and vaccine
study
women in five uptake in Latin America is due to factors related to pregnant
middlewomen, vaccine recommendations from healthcare
income
providers, and the health system. This article discusses
countries
women’s knowledge and attitudes to maternal immunization
participated in and the barriers to vaccination related to decision making
focus groups
processes in Latin America. In general, participants were
with
aware of the vaccine recommendation during pregnancy,
qualitative
but lacked knowledge about the diseases that are prevented
researchers
by the vaccines. These women also preferred getting more
detailed information from their providers than referring to
the internet for information about the vaccines. The
participants had positive attitudes towards maternal
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Guzman-Holst
et al.
(2020)

MetaAnalysis

Romer &
Jamieson
(2020)

Empirical
research

Ruiz & Bell
(2021)

Empirical
research
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immunization and were open to receiving vaccines during
pregnancy based on their trust of their provider’s
recommendations. It is also imperative to train healthcare
providers in health communication so that they can
effectively communicate with pregnant women about
maternal vaccines.
Review of
This is a systematic literature review of articles and studies
literature from focusing on barriers to vaccine access in Latin America.
nine online
Overall, the literature found that unfavorable socioeconomic
health
factors, lower levels of education, lack of awareness of
sciencediseases and vaccines, and religious and cultural beliefs
focused
often act as barriers to vaccination efforts. Furthermore, the
databases
studies found that vaccine uptake was more likely in those
with higher levels of education and those who trusted
healthcare workers.
1050 U.S
In this article, the authors discuss the polling of over 800
Englishparticipants to analyze the distribution of beliefs in
speaking
conspiracy theories related to the novel coronavirus. The
adults
polling determined that of the individuals who believed in at
participated in least one of the conspiracy theories, Hispanics and nona national
White respondents were more likely to believe in one of the
survey, 840
conspiracy theories. Additionally, the intent to vaccinate
were
was less related to politics and more related to personal
contacted at a beliefs.
later time to
review
Three conspiracy beliefs:
responses
1. The pharmaceutical industry created the coronavirus
to increase sales of its drugs and vaccines
2. The coronavirus was created by the Chinese
government as a biological weapon
3. Some in the U.S. Centers for Disease Control and
Prevention, CDC, are exaggerating the danger posed
by the coronavirus to damage the Trump presidency
804 U.S.
Englishspeaking
adults
participating
in online
survey

This article reviews the results of a public poll conducted
prior to the release of the COVID vaccine. In the poll,
participants completed a survey relating to vaccine
knowledge, COVID risk factors, and knowledge of the
novel coronavirus. The results found that overall, the
intentions of the participants to be vaccinated upon the
release of the vaccine were low. This was especially true for
Latinx and Black participants. Overall vaccine hesitancy
was determined by demographic characteristics, vaccine
knowledge, perceived vulnerability, risk factors of COVID19, and politics.
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Appendix C. GANTT Chart
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Appendix E. Survey for Phone Calls
1. Where do you get your information about COVID-19 from? De donde obtiene su
información sobre el COVID-19?
1. What do you know about COVID-19? ¿Qué sabe acerca del COVID-19?
2. Have you tested positive for COVID-19? ¿Ha dado positivo en la prueba de COVID-19?
3. Where do you get your information about the COVID-19 vaccine from? De donde
obtiene su información sobre la vacuna para el COVID-19?
What do you know about the COVID-19 vaccine? ¿Qué sabe acerca de la vacuna?
4. Do you have any concerns about the COVID-19 vaccine? Tiene preguntas o
preocupaciones acerca de la vacuna del COVID-19?
5. Are you aware of your eligibility for the COVID-19 vaccine? Usted sabe si es elegible
para la vacuna contra el COVID-19?
A. Yes: How did you know about your eligibility? ¿Cómo supo de su elegibilidad ?
B. No: Do you know how to find information about your eligibility? ¿Sabe
cómo encontrar información sobre su elegibilidad?
6. Do you receive other recommended vaccines like the flu vaccine? ¿Recibe otras vacunas
recomendadas como la vacuna contra la gripe?
7. Have you been recommended to get the COVID-19 vaccine? Le han recomendado recibir
la vacuna contra el COVID-19?
A. Yes: By who? Por quien?
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Appendix F. Educational Material for Phone Calls

Patient Responses/Statements

Health Professional Response

How do we know that these
vaccines are safe when they
are so new? Couldn’t they
cause problems that we don’t
know about yet? What about
long-term problems?

COVID-19 vaccines are being tested in large clinical trials to assess
their safety. However, it does take time, and more people getting
vaccinated before we learn about very rare or long-term side effects.
That is why safety monitoring will continue. CDC has an independent
group of experts that reviews all the safety data as it comes in and
provides regular safety updates. If a safety issue is detected, immediate
action will take place to determine if the issue is related to the
COVID-19 vaccine and determine the best course of action.

Can COVID-19 vaccine make No. None of the authorized and recommended vaccines contain the
me sick with COVID-19?
live virus that causes COVID-10. This means the vaccine cannot make
you sick with COVID-19.
There are several different types of vaccines in development. All of
them teach our immune systems how to recognize and fight the virus
that causes COVID-19. Sometimes this process can cause symptoms.
These symptoms are normal and a sign that the body is building
protection against the virus that causes COVID-19.
Will a COVID-19 vaccine
alter my DNA?

No. MRNA vaccines do not change or interact with your DNA in any
way. mRNA vaccines teach our cells how to make a protein that
triggers an immune response. COVID-19 mRNA vaccines work with
the body’s natural defenses to safely develop immunity to disease.

Is there a microchip in the
vaccine?

No, there is no microchip in the vaccine. These claims are baseless and
false. The vaccine vials have a list of ingredients made clear so
consumers can read them. These are also accessible via the internet.

How much will the shot hurt?

Your arm may be sore, red, or warm to the touch. These symptoms
usually go away on their own within a week.

After getting a COVID-19
vaccine, will I test positive
for COVID-19 on a viral test

No. Neither the recently authorized and recommended vaccines nor the
other COVID-19 vaccines currently in clinical trials in the United
States can cause you to test positive on viral tests, which are used to
see if you have a current infection

The COVID-19 vaccine was
rushed to the market or the
science was rushed.

The COVID-19 vaccines from Pfizer/BioNTech and Moderna were
created with a method that has been in development for years, so the
companies could start the vaccine development process early in the
pandemic
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China isolated and shared genetic information about COVID-19
promptly, so scientists could start working on vaccines.
The vaccine developers didn’t skip any testing steps, but conducted
some of the steps on an overlapping schedule to gather data faster.
Vaccine projects had plenty of resources, as governments invested in
research and/or paid for vaccines in advance.
Some types of COVID-19 vaccines were created using messenger
RNA (mRNA), which allows a faster approach than the traditional
way that vaccines are made.
Social media helped companies find and engage study volunteers, and
many were willing to help with COVID-19 vaccine research.
Because COVID-19 is so contagious and widespread, it did not take
long to see if the vaccine worked for the study volunteers who were
vaccinated.
The vaccine affects fertility in Confusion arose when a false report surfaced on social media, saying
women.
that the spike protein on this coronavirus was the same as another
spike protein called syncitin-1 that is involved in the growth and
attachment of the placenta during pregnancy. The two spike proteins
are completely different and distinct, and getting the COVID-19
vaccine will not affect the fertility of women who are seeking to
become pregnant, including through in vitro fertilization methods.
During the Pfizer vaccine tests, 23 women volunteers involved in the
study became pregnant, and the only one who suffered a pregnancy
loss had not received the actual vaccine, but a placebo.
I’ve already had COVID-19,
so I don’t need to get the
vaccine.

People who have gotten sick with COVID-19 may still benefit from
getting vaccinated. Due to the severe health risks associated with
COVID-19 and the fact that re-infection with COVID-19 is possible,
people may be advised to get a COVID-19 vaccine even if they have
been sick with COVID-19 before.
Yes, you should be vaccinated regardless of whether you already had
COVID-19. That’s because experts do not yet know how long you are
protected from getting sick again after recovering from COVID-19.

The side effects of COVID19 vaccine are dangerous.

The COVID-19 vaccine can have side effects, but the vast majority are
very short term —not serious or dangerous. The vaccine developers
report that some people experience pain where they were injected;
body aches; headaches or fever, lasting for a day or two. These are
signs that the vaccine is working to stimulate your immune system.

I won’t need to wear a mask
after I get the vaccine

-It may take time for everyone who wants a COVID-19 vaccination to
get one
-While the vaccine may prevent you from getting sick, it is unknown
at this time if you can still carry and transmit the virus to others. Until
more is understood about how well the vaccine works, continuing with
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precautions such as mask-wearing and physical distancing will be
important.
You can delay routine
vaccinations until after the
pandemic is over

No, you should keep up to date with any important adult vaccinations
and ensure children are kept up to date as well. There are ways to
ensure decreased risk of exposure and still allow you to get necessary
vaccines.

I heard the vaccine can alter
the results of my
mammogram. I am concerned
- does this mean the vaccine
will give me breast cancer?

No, the vaccine will not give you breast cancer. The reports regarding
mammogram results being influenced by the COVID vaccine are
based on the potential side effect of swollen lymph nodes. There are
lymph nodes located in the breasts, and the vaccine may cause them to
swell. This is not uncommon and it is a normal response to the
vaccine. If you plan on having a mammogram soon after receiving the
vaccine, please contact your provider to let them know about your
appointment.

The COVID-19 vaccine was
developed with or contains
controversial substances

The first two COVID-19 vaccines to be authorized by the USFDA
contain mRNA and other, normal vaccine ingredients, such as fats
(which protect the mRNA), salts, as well as a small amount of sugar.
These COVID-19 vaccines were not developed using fetal tissue, and
they do not contain any material, such as implants, microchips or
tracking devices.

Will it interfere with any
medications?

The vaccine should not interfere with most common medications like
blood pressure medications, diabetes medications, and thyroid
medications. If you are on immunosuppressant medications
(chemotherapy, high dose steroids), it is important to ask your doctor
about specific medications.

Will it be safe for people with
low or high blood pressure?
High cholesterol?

Yes, this vaccine is safe in people with medical conditions like high
blood pressure, DM, and high cholesterol. Patients with all of these
conditions were included in the vaccine trials.

Is it safe for older people?

Yes, the vaccine is safe in people of all ages >18yo for Moderna. More
than 20% of the patients in each of the trials were older than 65%
years. It is especially important to get vaccinated if you are older given
how dangerous the virus can be in the elderly/

If you are allergic to egg (flu
vaccine) can you still get the
COVID vaccine?

Yes, there are no egg products in the vaccine so you can still get the
vaccine
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Appendix I. Statement of Determination and Non-Research Determination Form
Student Name: Vanesa Vazquez, RN
Title of Project: Standardized Outreach: Increasing Vaccine Uptake in the Latinx

Community Through a Standardized Phone Call Process
Brief Description of Project
•
•

•
•
•

Data that Shows the Need for the Project: observations of community healthcare clinic
staff at the clinic-managed vaccination site determined long wait times for patients and
difficulty navigating the process for both the patients and staff
Aim Statement: We aim to improve the vaccination process at the community health
clinic COVID vaccination site in Oakland, California. The process begins with assessment
of the 5 Ps. The process end with improved vaccination rates. By working on the process,
we expect to reduce transmission of the novel coronavirus in this community. It is
important to work on this now because the community clinic serves a large population of
Latinx, undocumented, individuals with chronic illnesses, and low-income populations
who are also disproportionately affected by the virus. We want to encourage them to
receive the vaccine as soon as possible to prevent the spread of COVID-19.
Description of Intervention(s): Standardize outreach process to community clinic
patients
Desired Change in Practice: Improve outreach and documentation process for staff
members to study and adjust intervention
Outcome measurement(s) number of vaccine appointments made prior to the
intervention compared to the number of vaccine appointments made after the
intervention is implemented

To qualify as an Evidence-based Change in Practice Project, rather than a Research Project, the criteria
outlined in federal guidelines will be used: (http://answers.hhs.gov/ohrp/categories/1569)

☐

This project meets the guidelines for an Evidence-based Change in Practice Project as outlined in the

Project Checklist (attached). Student may proceed with implementation.

☐This project involves research with human subjects and must be submitted for IRB approval before
project activity can commence.

STANDARDIZED OUTREACH
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Comments:
EVIDENCE-BASED CHANGE OF PRACTICE PROJECT CHECKLIST *
Instructions: Answer YES or NO to each of the following statements:
Project Title:

YES

The aim of the project is to improve the process or delivery of care with
established/ accepted standards, or to implement evidence-based change. There is
no intention of using the data for research purposes.

x

The specific aim is to improve performance on a specific service or program and is
a part of usual care. ALL participants will receive standard of care.

x

The project is NOT designed to follow a research design, e.g., hypothesis testing or x
group comparison, randomization, control groups, prospective comparison groups,
cross-sectional, case control). The project does NOT follow a protocol that
overrides clinical decision-making.
The project involves implementation of established and tested quality standards
x
and/or systematic monitoring, assessment or evaluation of the organization to
ensure that existing quality standards are being met. The project does NOT develop
paradigms or untested methods or new untested standards.
The project involves implementation of care practices and interventions that are
consensus-based or evidence-based. The project does NOT seek to test an
intervention that is beyond current science and experience.

x

The project is conducted by staff where the project will take place and involves
staff who are working at an agency that has an agreement with USF SONHP.

x

The project has NO funding from federal agencies or research-focused
organizations and is not receiving funding for implementation research.

X

The agency or clinical practice unit agrees that this is a project that will be
x
implemented to improve the process or delivery of care, i.e., not a personal research
project that is dependent upon the voluntary participation of colleagues, students
and/ or patients.

NO

STANDARDIZED OUTREACH

If there is an intent to, or possibility of publishing your work, you and supervising
faculty and the agency oversight committee are comfortable with the following
statement in your methods section: “This project was undertaken as an Evidencebased change of practice project at X hospital or agency and as such was not
formally supervised by the Institutional Review Board.”
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x

ANSWER KEY: If the answer to ALL of these items is yes, the project can be considered an Evidencebased activity that does NOT meet the definition of research. IRB review is not required. Keep a copy
of this checklist in your files. If the answer to ANY of these questions is NO, you must submit for IRB
approval.

*Adapted with permission of Elizabeth L. Hohmann, MD, Director and Chair, Partners Human Research
Committee, Partners Health System, Boston, MA.

STUDENT NAME (Please print):

Vanesa Vazquez
Signature of Student:
(e-signature) Vanesa Vazquez, RN DATE 03/26/2021
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